GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Marketing Surveillance
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients who were attempted to implant the AC
• Thoracoabdominal aortic aneurysm
• Pararenal abdominal aortic aneurysm
Locations
Other Locations
Japan
The Jikei University Hospital
RECRUITING
Minatoku
Contact Information
Primary
Katsuyuki Niwa
kniwa@wlgore.com
+819017754499
Time Frame
Start Date: 2026-03-01
Estimated Completion Date: 2034-02-28
Participants
Target number of participants: 100
Treatments
TAMBE
Related Therapeutic Areas
Sponsors
Collaborators: CMIC Co, Ltd. Japan
Leads: W.L.Gore & Associates